FDA issues complete response letter for Merck’s chronic cough treatment
The regulatory agency sought further data linked to the measurement of efficacy.
Vishnu Priyan
Latest articles
All Articles
ProKidney signs SPAC merger deal with Social Capital Suvretta
ProKidney delivers disease-altering autologous cell therapy to treat chronic kidney disease.
Lilly and Evotec enter partnership for metabolic disease drug discovery
Evotec will receive undisclosed upfront, milestone and tiered royalty payments totalling up to $1bn.
Merck-Ridgeback to supply courses of Covid-19 oral antiviral to UNICEF
Merck will allocate the oral antiviral courses to UNICEF for supply in over 100 countries in the first half…
Abbisko Therapeutics and Lilly partner to develop new molecules
Abbisko is eligible to receive up to $258m in milestone payments from Lilly.
AstraZeneca-Daiichi Sankyo’s breast cancer therapy gets FDA priority review
The sBLA is based on results from the international, open-label Phase III DESTINY-Breast03 trial of Enhertu.
Health Canada grants authorisation to Pfizer’s Paxlovid for Covid-19
The authorised dosage is two tablets of nirmatrelvir and one tablet of ritonavir given orally twice daily for five…
Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19
The company will collaborate with the University of NSW and Macquarie University for vaccine development.
GSK rejects Unilever’s $68.4bn offer for Consumer Healthcare business
GSK noted that the bids ‘fundamentally undervalued’ the Consumer Healthcare business.